Facilitated Percutaneous Coronary Intervention in STEMI Patients: Does It Work in Asian Patients?
|
|
- Roland Dean
- 6 years ago
- Views:
Transcription
1 Editorial Comment Acta Cardiol Sin 2014;30: Facilitated Percutaneous Coronary Intervention in STEMI Patients: Does It Work in Asian Patients? Wei-Chun Huang, 1,2,3 Cheng-Hung Chiang 1,2 and Chun-Peng Liu 1,2 ST segment elevation myocardial infarction (STEMI) is one of major causes of morbidity and mortality in Asian and other patients worldwide. 1-3 There is substantial and important research dedicated to improving clinical outcomes for patients after STEMI. 1-8 Primary percutaneous coronary intervention (PCI) was shown to be more effective than thrombolytic therapy for the treatment of STEMI in centers with staff experienced with the PCI procedure. 1 However, reducing the time delay characteristic of primary PCI has remained a challenge in daily practice, especially in developing country. 2 Delays of time to treatment in transfer patients in real world might greatly exceed those times observed in randomized trials. 3,4 Therefore, early thrombolysis before PCI (facilitated PCI)mightresultinimprovedmyocardialsalvageand better long-term outcomes. Previous FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) study showed a potential benefit with a facilitated PCI in patients with higher risk, shorter symptom onset to randomization time, and an intermediate door-to-balloon time. 5 Furthermore, facilitated PCI with a combination of abciximab and a half-dose of reteplase was shown to improve survival at one year in high-risk patients presenting to a spoke (non-pci) hospital with symptom-to-randomization time less than 4 hours. 6 More recently, data from LIPSIA-STEMI (The Leipzig Immediate Prehospital Facilitated Angioplasty in ST- Received: June 16, 2013 Accepted: June 30, Cardiovascular Medical Center, Kaohsiung Veterans General Hospital, Kaohsiung; 2 School of Medicine, National Yang-Ming University, Taipei; 3 Department of Physical Therapy, Fooyin University, Kaohsiung, Taiwan. Address correspondence and reprint requests to: Dr. Chun-Peng Liu, Cardiovascular Medical Center, Kaohsiung Veterans General Hospital, No. 386, Dazhong 1st Rd., Zuoying Dist., Kaohsiung City 813, Taiwan. Tel: ; Fax: ; wchuanglulu. photo@gmail.com Segment Myocardial Infarction) trial, a fibrinolyticbased facilitated PCI approach with optimal antiplatelet co-medication was not shown to offer a benefit over primary PCI with respect to infarct size and tissue perfusion in STEMI patients presenting early after symptom onset with relatively long transfer times. 7 See page In this issue of the Acta Cardiologica Sinica, a study of early PCI after thrombolysis (facilitated PCI) via the transradial approach in Asian patients is published. 8 Despite the obvious limitations recognized by the authors of the study (which was done in a single center with small size and was not randomized with a selection bias of exclusion of cardiogenic shock), this study demonstrates that early PCI after thrombolysis via transradial artery approach is safe and efficacious for STEMI patients, which could be an alternative choice in patients with STEMI. Wang et al. presented the first study focusing on the safety and efficacy of thrombolysis followed by early PCI via transradial artery approach. 8 Previous facilitated PCI studies (Table 1) revealed different results as compared to primary PCI. The ASSENT-4 PCI trial. 9 showed facilitated PCI was associated with more major adverse events, including 90-day death or congestive heart failure or shock, than primary PCI. However, the FINESSE trial showed facilitated PCI improved survival at one year in high-risk patients presenting to a spoke (non-pci) hospital with symptom-to randomization time 4h. 6 Therefore, facilitated PCI might be benefit to STEMI patients arrived at non-pci hospital with long transfer to PCI hospital. The WEST, GRACIA-2, LIPSIA-STEMI, ATHENS PCI Trials, Agati et al. and De Luca et al. 7,10-14 revealed no differences between facilitated PCI and primary PCI in in-hospital, 30-day or 6-month death, re-infarction, refractory ischaemia, congestive heart failure, cardiogenic Acta Cardiol Sin 2014;30:
2
3
4 Facilitated PCI in STEMI shock, and ventricular arrhythmia; however, facilitated PCI might increase the risk of major bleeding complications (Table 1). Wang et al. also showed no significant difference in 30-day MACE between the facilitated PCI and primary PCI groups (p = 0.863). When compared to thrombolytic therapy with rescue PCI (Table 2), recent CARESS-in-AMI, TRANSFER-AMI and NORDISTEMI trials showed facilitated PCI had better outcomes, including 30-day or 12-month mortality, reinfarction, stroke, or new ischemia, especially in those hospitals located at rural areas with > 90-min transfer delays to PCI. The HUS-STEMI trial 20 also demonstrated pre-hospital fibrinolysis followed by routine early invasive evaluation provides an excellent reperfusion strategy for low-risk STEMI patients presenting early after symptom onset. Furthermore, after thrombolytic therapy in facilitated PCI patients, early PCI is critical to increase the possibility of improved outcomes in STEMI patients. In CARESS-in-AMI trial, 18 a reduced risk of death was observed if PCI after thrombolysis was performed within 3.35 hours from initial hospitalization (Table 2). In a study by Wang et al., 8 the thrombolysis to balloon time was hours, which might explain the equivocal results. Facilitated PCI with early pharmacologic reperfusion before PCI can lead to myocardial salvage. Wang et al. 8 showed the safety of facilitated PCI for Asian STEMI patients with a similar 30-day MACE as the primary PCI groups. However, future randomized trials should investigate whether this strategy may further improve outcome in Asian patients, especially in patients who arrived at non-pci hospital after a long transfer time to PCI hospital. ACKNOWLEDGEMENT This article was supported by the Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Grant No. VGHKS , , REFERENCES 1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a 295 Acta Cardiol Sin 2014;30:
5
6 Wei-Chun Huang et al. quantitative review of 23 randomised trials. Lancet 2003;361: De Luca G, Suryapranata H, Ottervanga JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction. Circulation 2004;109: Nallamothu BK, Bates ER, Herrin J, et al., NRMI Investigators. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005;111: Herrmann HC. Transfer for primary angioplasty: the importance of time. Circulation 2005;111: Ellis SG, Tendera M, de Belder MA, et al., Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008;358: Herrmann HC, Lu J, Brodie BR, et al., FINESSE Investigators. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. J Am Coll Cardiol Intv 2009;2: Thiele H, Eitel I, Meinberg C, et al., Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). JACC Cardiovasc Interv 2011;4: Wang YB, Fu XH, Gu XS, et al. Thrombolysis followed by early percutaneous coronary intervention via transradial artery approach in patients with ST-segment elevation infarction. Acta Cardiol Sin 2014;30: Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet : Armstrong PW, WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006;13: Fernández-Avilés F, Alonso JJ, Peña G, et al., Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J 2007;8: Kanakakis J, Nanas JN, Tsagalou EP, et al. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial. Catheter Cardiovasc Interv 2009; 74: Agati L, Funaro S, Madonna M, et al. Does coronary angioplasty after timely thrombolysis improve microvascular perfusion and left ventricular function after acute myocardial infarction? Am Heart J 2007;154: De Luca G, Marino P. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Am J Emerg Med 2009;27: Di Mario C, Dudek D, Piscione F, et al., Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008;371: Cantor WJ, Fitchett D, Borgundvaag B, et al., Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009;360: Bøhmer E, Hoffmann P, Abdelnoor M, et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol 2010;55: Dimopoulos K, Dudek D, Piscione F, et al., Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial. Int J Cardiol 2012;154: Bagai A, Cantor WJ, Tan M, et al. Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANS- FER-AMI) study. Am Heart J 2013;165: Viikilä J, Lilleberg J, Tierala I, et al., Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction: the Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction (HUS- STEMI). Eur Heart J Acute Cardiovasc Care 2013;2: Acta Cardiol Sin 2014;30:
PCI Strategies After Fibrinolytic Therapy
PCI Strategies After Fibrinolytic Therapy How to choose the appropriate reperfusion strategy. BY MICHEL R. LE MAY, MD Survival in patients presenting with ST-segment elevation myocardial infarction (STEMI)
More informationJACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 6, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 6, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.02.012 MINI-FOCUS
More informationAt the most severe end of the spectrum of acute coronary syndromes is ST-segment
Focused Issue of This Month Reperfusion Strategies in Acute ST-segment Elevation Myocardial Infarction Young-Jo Kim, MD Division of Cardiology, Department of Internal Medicine, Yeungnam University College
More informationCritics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS
Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS STEMI Stuff New or Recurrent MI s in U.S.: 865,000 Acute STEMI s: 500,000 Sooner
More informationFacilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?
Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at
More informationTransfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem
Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927
More informationST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED
ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED W. Brian Gibler, MD Professor and Chairman; Department of Emergency Medicine, University of Cincinnati College
More informationAcute Coronary Syndrome (ACS) is the consequence of
Clinical Practice Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand Pradub Sukhum, MD. 1 1 Division of Cardiovascular Medicine, Bangkok
More informationDrug-eluting stents and glycoprotein IIbIIIa inhibitors in the pharmacoinvasive management of ST elevation MI
Priority paper evaluation Drug-eluting stents and glycoprotein IIbIIIa inhibitors in the pharmacoinvasive management of ST elevation MI Evaluation of: Sanchez, P, Gimeno F, Ancillo P et al.: Role of the
More informationPharmaco-Invasive Approach for STEMI
Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),
More informationPPCI in STEMI. ESC at the 22nd Annual Conference of the Saudi Heart Association February 21th, 2011
PPCI in STEMI Dr Hassan Mhish Interventional Cardiology Consultant Cardiology Fellowship Program Director Prince Salman Heart Center King Fahd Medical City Riyadh, KSA ESC at the 22nd Annual Conference
More informationPatient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough
Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough Current Management Strategies for ACS ACS No ST Elevation ST ST Elevation Elevation Early Invasive Early Conservative Fibrinolysis
More informationThe optimum reperfusion pathway for ST elevation acute myocardial infarction: development of a decision framework
52 PREHOSPITAL CARE The optimum reperfusion pathway for ST elevation acute myocardial infarction: development of a decision framework J Kendall... There is currently much debate about the relative roles
More informationCurrent Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach
Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants
More informationThe restoration of coronary flow after an
Pharmacological Reperfusion in Acute Myicardial Infarction after ASSENT 3 and GUSTO V [81] DANIEL FERREIRA, MD, FESC Serviço de Cardiologia, Hospital Fernando Fonseca, Amadora, Portugal Rev Port Cardiol
More informationOptimizing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction
EDITORIAL Optimizing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction In an ideal world, all patients with [ST-segment elevation myocardial infarction] would be
More informationThrombolysis in the Era of Intervention
26 SUPPLEMENT TO JAPI december 2011 VOL. 59 Thrombolysis in the Era of Intervention SS Iyengar *, Girish S Godbole ** Abstract Thrombolysis revolutionized the treatment of acute ST elevation myocardial
More informationPRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE
PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE Walid Sawalha MD, MBBS (Lond), MRCP(UK)* ABSTRACT Objectives:
More informationSTEMI Network. Joseph L. Fredi, M.D., FACC. The median D2B time for patients presenting to the Vanderbilt ED was 55 minutes.
STEMI Network STEMI News By Joseph Fredi, M.D., FACC, and Carol R. Scott, B.S.N., M.S.N., coordinators, STEMI Network, Vanderbilt Heart and Vascular Institute Even with the great success our STEMI Network
More informationThe Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium
The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications
More informationRecommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies
Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Chairman, Faculty of Cardiology,
More informationRoule et al. Critical Care (2016) 20:359 DOI /s z
Roule et al. Critical Care (2016) 20:359 DOI 10.1186/s13054-016-1530-z RESEARCH Open Access Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction:
More informationDecision for fibrinolysis or primary PCI in the prehospital phase
Decision for fibrinolysis or primary PCI in the prehospital phase Nicolas Danchin, Hôpital Européen Georges Pompidou, Paris, France Disclosures Research grants: Astrazeneca, Eli-Lilly, GSK, Merck, Novartis,
More informationJACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 5, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 5, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2008.06.009 Reduced-Dose
More informationRegional STEMI Transfer Systems: the Mayo and NC RACE Experiences
Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences Dr. Henry H. Ting, Mayo Clinic College of Medicine Dr. James G. Jollis,, Duke University Medical Center Mayo Clinic STEMI System for Transferred
More informationSuranaree J. Sci. Technol. Vol. 22 No. 4; October - December 2015
Suranaree J. Sci. Technol. Vol. 22 No. 4; October - December 2015 369 COMPARING MORTALITY AND COMPLICATIONS IN STEMI BETWEEN TWO TREATMENT GROUPS: PRIMARY PCI AND PHARMACO-INVASIVE GROUPS: MAHARAT NAKHON
More informationORIGINAL INVESTIGATION
ORIGINAL INVESTIGATION Contemporary Mortality Differences Between Primary Percutaneous Coronary Intervention and Thrombolysis in ST-Segment Elevation Myocardial Infarction Marc J. Claeys, MD, PhD; Antoine
More informationAll Patients Treated with Thrombolytic Agents Should Undergo a Pharmacoinvasive Strategy in the First 24 Hours
All Patients Treated with Thrombolytic Agents Should Undergo a Pharmacoinvasive Strategy in the First 24 Hours Agonist MARCELO O. BETTINOTTI MTSAC, 1 ST-segment elevation myocardial infarction (STEMI)
More informationCardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008.
Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008. ST Elevation Myocardial Infarction (STEMI)-Acute Coronary Syndrome Guidelines:
More informationThe Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:
The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: Nathaniel Niles, MD CREST Symposium November 7th, 28 STEMI = Acute Coronary Thrombosis STEMI
More informationORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI
Heart Mirror Journal From Affiliated Egyptian Universities and Cardiology Centers Vol. 6, No. 3, 2012 ISSN 1687-6652 ORIGINAL ARTICLE for Failed Fibrinolysis in Patients with STEMI Mohamed Salem, MD, PhD;
More informationManagement of Cardiogenic shock. Prof. Christian JM Vrints
Management of Cardiogenic shock Prof. Christian JM Vrints none conflicts Management of Cardiogenic Shock Incidence and trends Importance of early revascularization Multivessel disease Left main disease
More informationThe role of pre hospital thrombolysis. Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel
The role of pre hospital thrombolysis Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel Is thrombolysis still valid? Disclosure I am an Interventional Cardiologist STEMI is mainly a thrombotic
More informationLong-Term Prognostic Value of ST-Segment Resolution in Patients Treated With Fibrinolysis or Primary Percutaneous Coronary Intervention
Journal of the American College of Cardiology Vol. 54, No. 19, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.03.084
More informationST-elevation myocardial infarctions (STEMIs)
Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More informationST-segment Elevation Myocardial Infarction (STEMI): Optimal Antiplatelet and Anti-thrombotic Therapy in the Emergency Department
ST-segment Elevation Myocardial Infarction (STEMI): Optimal Antiplatelet and Anti-thrombotic Therapy in the Emergency Department decision-making. They have become the cornerstone of many ED protocols for
More informationPost-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study)
30 Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study) RK Singh 1, A Trailokya 2, MM Naik 3 Original Article Abstract Background: ST elevated myocardial infarction
More informationACUTE CORONARY SYNDROME PCI IN THE ELDERLY
ACUTE CORONARY SYNDROME PCI IN THE ELDERLY G.KARABELA MD.PhD ATHENS NAVAL HOSPITAL INTERVENTIONAL CARDIOLOGY DEPARTMENT NO CONFLICT OF INTEREST TO DECLAIRE Risk stratification in Αcute Coronary Syndrome.
More informationLong-Term Follow-Up of Early Versus Delayed Invasive Approach After Fibrinolysis in Acute Myocardial Infarction
Long-Term Follow-Up of Early Versus Delayed Invasive Approach After Fibrinolysis in Acute Myocardial Infarction Yvonne P. Clever, MD; Bodo Cremers, MD; Andreas Link, MD; Michael Böhm, MD; Bruno Scheller,
More informationImproving the Outcomes of
Improving the Outcomes of STEMI Shelley Valaire, ACP; and Robert Welsh, MD, FRCPC Presented at the University of Alberta s 6th Annual Cardiology Update for General Practitioners and Internists, Edmonton,
More informationpresenters 2010 Sameh Sabet Ain Shams University
Guidelines for PCI in late STEMI presenters 2010 Sameh Sabet Assistant Professor of Cardiology Ain Shams University 29% of MI patients have STEMI. NRMI 4 (Fourth National Registry of Myocardial Infarction),
More informationNova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Multivessel disease and cardiogenic shock: CABG is the optimal revascularization therapy. Contra Prof. Christian JM Vrints Cardiogenic Shock Spiral Acute Myocardial
More informationIntraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
More informationManagement of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police
Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis
More informationInternational Journal of Biomedicine 8(1) (2018) ORIGINAL ARTICLE. Cardiology
International Journal of Biomedicine 8(1) (2018) 15-19 http://dx.doi.org/10.21103/article8(1)_oa1 ORIGINAL ARTICLE INTERNATIONAL JOURNAL OF BIOMEDICINE Cardiology Percutaneous Coronary Interventions in
More informationTAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools
TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools Material inside brackets ([and]) is new to this Specifications Manual version. Hospital Outpatient Quality Measures Acute Myocardial Infarction
More informationThe Strategic Reperfusion Early After STEMI study Implications for clinical practice
The Strategic Reperfusion Early After STEMI study Implications for clinical practice Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization and Interventional
More informationSTEMI Care 2014 at the Crossroads: Taking the right road
STEMI Care 2014 at the Crossroads: Taking the right road Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Vice President, The Canadian Association of Interventional Cardiology Director,
More informationDownloaded from ismj.bpums.ac.ir at 22: on Thursday March 7th 2019
- ( ) - ST. :. (No-reflow). ST :.. SPSS. ( / ) :.(P
More informationSTREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve
STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION PCI Hospital Ambulance/ER STREAM design STEMI
More informationPrimary Percutaneous Coronary Intervention
The big 5 in PCI Primary Percutaneous Coronary Intervention W. Wijns (Aalst, BE) Disclosures Consulting Fees: on my behalf go to the Cardiovascular Research Center Aalst Contracted Research between the
More informationQuale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor
Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor Leonardo Bolognese Cardiovascular Department, Arezzo, Italy Platelet Reactivity in Patients with STEMI Undergoing Primary PCI Campo G et
More informationST-segment myocardial infarction (STEMI) is caused by
Review Article Recommendations for an efficient and safe use of fibrinolytic agents ST-segment myocardial infarction (STEMI) is caused by thrombotic occlusion of a major coronary artery. Rapid restoration
More informationLiterature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction
Literature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction EMS Bureau Protocol Review Steering Committee Background In 2009, approximately 683,000 Americans
More informationPrimary PCI versus thrombolytic therapy: long-term follow-up according to infarct location
Heart Online First, published on April 14, 2005 as 10.1136/hrt.2005.060152 1 Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location Short running head: Anterior infarction
More informationA Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction
T h e n e w e ng l a nd j o u r na l o f m e dic i n e original article A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction Michel R. Le May, M.D., Derek Y. So, M.D., Richard
More informationEffects of streptokinase on reflow in rescue percutaneous coronary intervention. Original Article
Effects of streptokinase on reflow in rescue percutaneous coronary intervention Abstract Masoud Sanatkar (1), Hassan Shemirani (2), Hamid Sanei (3), Masoud Pourmoghaddas (4), Katayoun Rabiei (5) Original
More informationManagement of Acute Myocardial Infarction
Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care
More informationPrimary Angioplasty and Thrombolysis for the Treatment of Acute ST- Segment Elevated Myocardial Infarction
Ontario Health Technology Assessment Series 2010; Vol. 10, No. 17 Primary Angioplasty and Thrombolysis for the Treatment of Acute ST- Segment Elevated Myocardial Infarction An Evidence Update Presented
More informationNEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association
NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationThe use of percutaneous coronary intervention
Elective PCI Without On-Site Cardiac : Standard of Care? The performance of PCI without on-site cardiac surgery remains controversial and continues to be debated in the US. BY GREGORY J. DEHMER, MD Although
More informationStrategies in mechanical interventions for acute MI: facilitated and rescue PCI
NORMAL INTERVENTIONAL TC-99M MIBI STRATEGY MYOCARDIAL FOR PERFUSION ACUTE MI Strategies in mechanical interventions for acute MI: facilitated and rescue PCI Farrel Hellig Sunninghill, Sunward Park and
More informationc01 BLBK225-Meier October 14, :18 Char Count= PART I Coronary Artery Disease COPYRIGHTED MATERIAL
PART I Coronary Artery Disease COPYRIGHTED MATERIAL CHAPTER 1 Acute Coronary Syndromes Pierre-Frédéric Keller and Marco Roffi Division of Cardiology, University Hospital of Geneva, Geneva, Switzerland
More informationM/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl #
Acute Coronary Syndrome - Case Review - Young-Guk Ko, MD Yonsei Cardiovascular Center Yonsei University College of Medicine Case 1 M/39 #4306212 CC D : Severe squeezing chest pain : 4 hours, aggravated
More informationThe Appropriate Management of Rural Patients with ST-Segment Elevation Myocardial Infarction When Delays are Expected Due to Long-Distance Transfers
Pacific University CommonKnowledge School of Physician Assistant Studies Theses, Dissertations and Capstone Projects Summer 8-8-2014 The Appropriate Management of Rural Patients with ST-Segment Elevation
More informationAs reviewed in part I of this report, 1 primary PCI without
Advances in Interventional Cardiology Angioplasty Strategies in ST-Segment Elevation Myocardial Infarction Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future
More informationAcute Coronary Syndrome: Interventional Strategy
2005 Acute Coronary Syndrome: Interventional Strategy Youngkeun Ahn, MD, PhD, FACC, FSCAI Department of Cardiology Program in Gene and Cell Therapy, The Heart Center of Chonnam National University, GwangJu,,
More informationControversies on Primary angioplasty in STEMI
Controversies on Primary angioplasty in STEMI 원주의대이승환 Case ( 51/M) CC C.C: ongoing squeezing chest pain D : for 2 hours Risk factors Current smoker ( 40 PYs) Hypercholesterolemia (+) Case ( 51/M) Physical
More informationPatient and System Time Delay
Quality Indicators in the Management of ST-elevation Myocardial Infarction Patient and System Time Delay Jacob Thorsted Sorensen, MD, PhD Department of Cardiology Aarhus University Hospital, Denmark Disclosures
More informationPreprocedural TIMI Flow and Mortality in Patients With Acute Myocardial Infarction Treated by Primary Angioplasty
Journal of the American College of Cardiology Vol. 43, No. 8, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.11.042
More informationSystems of Care to Improve Timeliness of Reperfusion Therapy for ST-Segment Elevation Myocardial Infarction During Off Hours
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 1, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER DOI: 10.1016/j.jcin.2007.10.002 Systems of Care
More informationSTEMI AND MULTIVESSEL CORONARY DISEASE
STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related
More informationHyang Ki Min, Ji Young Park, Jae Woong Choi, Sung Kee Ryu, Seunghwan Kim, Chang Sup Song, Dong Shin Kim, Chi Woo Song, Se Jong Kim, Young Bin Kim
ORIGINAL ARTICLE eissn 2384-0293 Yeungnam Univ J Med 2017;34(2):191-199 https://doi.org/10.12701/yujm.2017.34.2.191 Long-term clinical outcome of acute myocardial infarction according to the early revascularization
More informationIschemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
More informationSTEMI: Newer Aspects in Pharmacological Treatment
CHAPTER 14 STEMI: Newer Aspects in Pharmacological Treatment P. C. Manoria, Pankaj Manoria Introduction ST elevation myocardial infarction (STEMI) commonly results from disruption of a vulnerable plaque
More informationThrombolysis in Acute Myocardial Infarction
CHAPTER 70 Thrombolysis in Acute Myocardial Infarction J. S. Hiremath Introduction Reperfusion of the occluded coronary artery at the earliest is the most important aim of management of STEMI. Once a flow
More informationReperfusion therapy for ST-segment elevation myocardial infarction: a review of the available treatment options in Kuwait
Reperfusion therapy for ST-segment elevation myocardial infarction: a review of the available treatment options in Kuwait Mohammad Zubaid 1, Wafa A. Rashed 2, Mustafa Ridha 3 CME Acute myocardial infarction
More informationUpdated and Guideline Based Treatment of Patients with STEMI
Updated and Guideline Based Treatment of Patients with STEMI Eli I. Lev, MD Director, Cardiac Catheterization Laboratory Hasharon Hospital, Rabin Medical Center Associate Professor of Cardiology Tel-Aviv
More informationMethods Individual patient data from CAPTIM (n = 840, ) and the more recent WEST trial (n = 328, ) were pooled.
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous
More informationParamedic CAT (Critically Appraised Topic) Worksheet Title: Treating STEMI in the pre-hospital setting with a thrombolytic vs fibrinolytic drug
Paramedic CAT (Critically Appraised Topic) Worksheet Title: Treating STEMI in the pre-hospital setting with a thrombolytic vs fibrinolytic drug Report by: Matthew Pusateri Clinical Scenario: A 56 year
More informationREFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO
REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients
More informationEffect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden
More informationTHE CURRENT SITUATION AND FUTURE OF THE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROM IN RUSSIAN FEDERATION
: 616.127-005.8 -..,.. -...,, ( ), 2011, 581 182. 195 592 ( ) 385 590 -. 4,3 % 8,8 % ( ). 2011 62 329,, 24 931 (40 %) -. : - - ; ; 70 % ST ( ST); ST - 24. : ST,. THE CURRENT SITUATION AND FUTURE OF THE
More information12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2
Coronary Artery Pathophysiology ACS / AMI LeRoy E. Rabbani, MD Director, Cardiac Inpatient Services Director, Cardiac Intensive Care Unit Professor of Clinical Medicine Major Determinants of Myocardial
More informationRescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction
Journal of the American College of Cardiology Vol. 49, No. 4, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.09.033
More informationThe development of cardiogenic shock portends an extremely poor prognosis. Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction
TREATMENT UPDATE Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction David R. Holmes, Jr, MD Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN Cardiogenic shock is a serious
More informationRecurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy
Case Report Acta Cardiol Sin 2013;29:462 466 Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy Hung-Hao Lee, 1 Tsung-Hsien
More informationConcurrent Subarachnoid Hemorrhage and Acute Myocardial Infarction: A Case Report
Concurrent subarachnoid hemorrhage and AMI 155 Concurrent Subarachnoid Hemorrhage and Acute Myocardial Infarction: A Case Report Chen-Chuan Cheng 1, Wen-Shiann Wu 1, Chun-Yen Chiang 1, Tsuei-Yuang Huang
More informationThe Need for Rescue PCI after Failed Fibrinolysis: Who, When and Why.
Implementing the pharmacoinvasive strategy in STEMI The Need for Rescue PCI after Failed Fibrinolysis: Who, When and Why. 7:20-7:40 Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Director,
More informationTarget vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI
Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional
More informationIABP SHOCK II trial:
IABP SHOCK II trial: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic
More informationSummary and conclusions. Summary and conclusions
Summary and conclusions 183 184 Summary and conclusions In this thesis several aspects of the treatment of ST-segment elevation myocardial infarction (STEMI) by primary angioplasty have been analyzed.
More informationRole of platelet glycoprotein IIb/IIIa inhibitors in rescue percutaneous coronary interventions
Role of platelet glycoprotein IIb/IIIa inhibitors in rescue percutaneous coronary interventions Anna Sonia Petronio, Marco De Carlo, Roberta Rossini, Giovanni Amoroso, Ugo Limbruno, Nicola Ciabatti, Caterina
More informationOptimizing care for ST-elevation myocardial infarction patients: application of systems engineering
Journal of Geriatric Cardiology (2016) 13: 883 887 2016 JGC All rights reserved; www.jgc301.com Editorial Open Access Optimizing care for ST-elevation myocardial infarction patients: application of systems
More informationMædica - a Journal of Clinical Medicine
MAEDICA a Journal of Clinical Medicine 2013; 8(2): 103-107 Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Early Clinical Outcomes of Primary Percutaneous Coronary Intervention in Bharatpur, Nepal
More informationSTEMI Primary Percutaneous Coronary Intervention
STEMI Primary Percutaneous Coronary Intervention Abdul Razek Maaty, MD Professor of Medicine Outline Primary PCI Aspiration, manual thrombectomy and distal protection devices Choice of stent Pharmacothaerpy,
More information